🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 22 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 31/07/2006 | 34,81 | 35,56 | 34,36 | 34,55 | -1,28% | 3,44% | 105.558 |
| 28/07/2006 | 35,90 | 35,93 | 34,81 | 35,00 | -1,58% | 3,13% | 25.034 |
| 27/07/2006 | 35,90 | 35,93 | 34,44 | 35,56 | +0,00% | 4,17% | 28.480 |
| 26/07/2006 | 33,69 | 35,86 | 33,69 | 35,56 | +4,97% | 6,44% | 240.183 |
| 25/07/2006 | 33,87 | 34,40 | 33,50 | 33,87 | +0,00% | 2,65% | 160.647 |
| 24/07/2006 | 33,13 | 34,06 | 32,98 | 33,87 | +3,78% | 3,28% | 228.347 |
| 21/07/2006 | 32,75 | 32,98 | 32,45 | 32,64 | -0,91% | 1,60% | 79.429 |
| 20/07/2006 | 32,56 | 34,59 | 32,49 | 32,94 | +2,80% | 6,44% | 128.507 |
| 19/07/2006 | 30,51 | 32,60 | 30,51 | 32,04 | +3,76% | 6,87% | 187.417 |
| 18/07/2006 | 29,76 | 31,63 | 29,76 | 30,88 | +3,77% | 6,29% | 88.031 |
| 17/07/2006 | 29,49 | 30,24 | 29,38 | 29,76 | -0,75% | 2,92% | 145.606 |
| 14/07/2006 | 31,03 | 31,03 | 29,12 | 29,98 | -2,55% | 6,15% | 99.172 |
| 13/07/2006 | 32,19 | 32,19 | 30,54 | 30,77 | -2,26% | 5,12% | 37.858 |
| 12/07/2006 | 32,53 | 32,53 | 31,40 | 31,48 | -2,44% | 3,45% | 50.575 |
| 11/07/2006 | 31,44 | 32,49 | 31,07 | 32,26 | +3,11% | 4,52% | 85.948 |
| 10/07/2006 | 32,38 | 32,56 | 31,07 | 31,29 | -2,22% | 4,62% | 134.759 |
| 07/07/2006 | 31,85 | 32,38 | 31,63 | 32,00 | +0,59% | 2,35% | 53.701 |
| 06/07/2006 | 31,44 | 32,75 | 31,18 | 31,82 | +0,71% | 5,00% | 82.955 |
| 05/07/2006 | 31,63 | 32,11 | 29,98 | 31,59 | +0,48% | 6,75% | 90.676 |
| 03/07/2006 | 31,29 | 31,67 | 30,32 | 31,44 | -0,59% | 4,31% | 72.509 |
| 30/06/2006 | 32,38 | 33,69 | 31,29 | 31,63 | -1,17% | 7,40% | 147.770 |
| 29/06/2006 | 32,19 | 32,34 | 31,25 | 32,00 | +0,35% | 3,37% | 189.101 |
| 28/06/2006 | 33,13 | 33,13 | 31,74 | 31,89 | -2,63% | 4,18% | 170.292 |
| 27/06/2006 | 33,69 | 34,21 | 31,89 | 32,75 | -2,23% | 6,89% | 124.500 |
| 26/06/2006 | 34,44 | 34,44 | 32,94 | 33,50 | -2,93% | 4,35% | 70.078 |
| 23/06/2006 | 33,50 | 34,81 | 32,60 | 34,51 | +1,99% | 6,59% | 101.523 |
| 22/06/2006 | 35,00 | 35,00 | 33,69 | 33,84 | -1,74% | 3,74% | 112.504 |
| 21/06/2006 | 34,62 | 34,92 | 34,06 | 34,44 | +1,32% | 2,49% | 487.953 |
| 20/06/2006 | 35,15 | 35,56 | 33,50 | 33,99 | -2,99% | 5,86% | 90.543 |
| 19/06/2006 | 36,53 | 37,43 | 34,62 | 35,03 | -5,45% | 7,68% | 117.233 |